As SCA communicated in December 2016, the Group has entered into an agreement to acquire BSN medical, a leading medical solutions company. Closing is expected to take place during the second quarter 2017. BSN medical’s sales for 2016 amounted to EUR 850m (SEK 8,038m) and adjusted EBITDA1) for 2016 amounted to EUR 210m (SEK 1,986m).
1)Excluding items affecting comparability
NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 20:00 CET on March 9, 2017.
Karl Stoltz, Media Relations Manager, +46 8 788 51 55
For additional information please contact:
Johan Karlsson, Vice President Investor Relations, 46 (0)8 788 51 30
Karl Stoltz, Media Relations Manager, 46 (0)8 788 51 55